Roche Pharmaceuticals A/S

Roche Pharmaceuticals A/S (CVR number: 25230515) is a company from KØBENHAVN. The company reported a net sales of 761.4 mDKK in 2023, demonstrating a decline of -3.1 % compared to the previous year. The operating profit percentage was at 5.6 % (EBIT: 42.9 mDKK), while net earnings were 36.5 mDKK. The profitability of the company measured by Return on Assets (ROA) was 11.9 %, which can be considered good but Return on Equity (ROE) was 24.1 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 39 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Roche Pharmaceuticals A/S's liquidity measured by quick ratio was 0.9 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.